149057-19-2

Basic information

• Product Name: N-1-BOC-N-4-CBZ-2-PIPERAZINE CARBOXYLIC ACID
• Synonyms: PIPERAZINE-1,2,4-TRICARBOXYLIC ACID 4-BENZYL ESTER 1-TERT-BUTYL ESTER;PIPERAZINE-2-CARBOXYLIC ACID, N1-BOC PROTECTED, N4-CBZ PROTECTED;N-1-BOC-N-4-CBZ-2-PIPERAZINE CARBOXYLIC ACID;1-BOC-4-CBZ-PIPERAZINE-2-CARBOXYLIC ACID;4-[(BENZYLOXY)CARBONYL]-1-(TERT-BUTOXYCARBONYL)PIPERAZINE-2-CARBOXYLIC ACID;REF DUPL: N-1-Boc-N-4-Cbz-2-Piperazine carboxylic acid;1-N-BOC-4-N-Cbz-piperazine-2-carboxylic acid;4-Cbz-1-Boc-Piperazine-2-carboxylic acid
• CAS NO: 149057-19-2
• Molecular Formula: C₁₈H₂₄N₂O₆
• Molecular Weight: 364.39
• Mol File: 149057-19-2.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 518.912 °C at 760 mmHg
• Flash Point: 267.629 °C
• Appearance: /
• Density: 1.272
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.69±0.20(Predicted)
• CAS DataBase Reference: N-1-BOC-N-4-CBZ-2-PIPERAZINE CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: N-1-BOC-N-4-CBZ-2-PIPERAZINE CARBOXYLIC ACID(149057-19-2)
• EPA Substance Registry System: N-1-BOC-N-4-CBZ-2-PIPERAZINE CARBOXYLIC ACID(149057-19-2)

Safety Data

• Hazardous Substances Data: 149057-19-2(Hazardous Substances Data)

Usage

Uses

4-((Benzyloxy)carbonyl)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid is a useful intermediate used in the preparation of N-aryl piperazines as new CXCR4 antagonists and antivirals.

Upstream product

• 1214196-85-6 1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid 
• 501-53-1 benzyl chloroformate 
• 1279816-75-9 C₂₀H₂₈N₂O₆ 
• 2762-32-5 piperazine-2-carboxylic acid 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 58632-95-4 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile 
• 24424-99-5 di-tert-butyl dicarbonate 
• 934630-06-5 4-(benzyloxy-carbonyl)-2-piperazinecarboxylic acid 
• 129799-14-0 4-benzyl 1-(tert-butyl) 2-methyl piperazine-1,2,4-tricarboxylate 

Downstream Products

• 569348-20-5 4-benzyl 1-(tert-butyl) 2-carbamoylpiperazine-1,4-dicarboxylate 
• 1259014-00-0 4-benzyl 1-tert-butyl 2-(methylcarbamoyl)piperazine-1,4-dicarboxylate 
• 1311151-00-4 C₂₉H₃₀F₃N₃O₆S 
• 1311151-19-5 C₂₇H₂₆F₃N₃O₆S 
• 1311151-21-9 C₂₇H₃₂F₃N₃O₆S 
• 1311151-23-1 C₂₇H₂₅F₄N₃O₆S 
• 1311151-25-3 C₂₈H₂₈F₃N₃O₆S 
• 1311151-27-5 C₂₈H₂₅F₆N₃O₇S 
• 1311151-30-0 C₂₈H₂₅F₆N₃O₆S 
• 1311151-34-4 C₂₈H₂₅F₆N₃O₇S 
• 1311151-36-6 C₂₈H₂₅F₆N₃O₆S 
• 1311151-38-8 C₃₃H₃₀F₃N₃O₆S 
• 1311151-40-2 C₂₈H₂₈F₃N₃O₇S 
• 1311151-42-4 C₂₇H₂₅F₄N₃O₆S 

Relevant articles and documents

SMALL MOLECULES THAT SENSITIZE HIV-1 INFECTED CELLS TO ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY

Compounds and methods of treating HIV-1 in a human infected with HIV-1 or preventing HIV-1 infection in a human susceptible to infection with HIV-1 are provided. The compounds are of formula (I), (II), and (IA), wherein R1-R7, X, X', Y, Y', Z, and n are defined herein, and the methods comprises administering therapeutically effective amounts of these compounds to the human.

SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS

There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin and/or kallikrein, which compounds include substituted pyrazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which diseases or disorders are amenable to treatment or prevention by the inhibition of thrombin and/or kallikrein.

OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE

Compounds and compositions of said compounds along with methods of use of compounds are disclosed for treating ophthalmic conditions related to mislocalization of opsin proteins, the misfolding of mutant opsin proteins and the production of toxic visual cycle products that accumulate in the eye. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described.